Creative Biolabs offers expert services for the development of antibodies targeting the F13L protein of monkeypox virus (MPXV), a vital component in understanding the pathogenesis of the virus and its immune evasion mechanisms. The F13L gene of monkeypox encodes a protein that plays a crucial role in the virus's ability to inhibit host immune responses, particularly the antiviral activity of interferons. As MPXV continues to be a global health concern, antibody-based research tools against this protein have become pivotal for studying viral replication, immune modulation, and potential vaccine development.